These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11080041)
21. Agents that target telomerase and telomeres. Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642 [TBL] [Abstract][Full Text] [Related]
22. Protein and RNA of human telomerase as targets for modified oligonucleotides. von Janta-Lipinski M; Gaertner K; Lehmann C; Scheer H; Schildt J; Matthes E Nucleosides Nucleotides; 1999; 18(6-7):1719-20. PubMed ID: 10474255 [TBL] [Abstract][Full Text] [Related]
23. [Telomerase inhibitor]. Kyo S; Inoue M Gan To Kagaku Ryoho; 2001 May; 28(5):614-21. PubMed ID: 11383209 [TBL] [Abstract][Full Text] [Related]
24. New prospects for targeting telomerase beyond the telomere. Arndt GM; MacKenzie KL Nat Rev Cancer; 2016 Aug; 16(8):508-24. PubMed ID: 27339602 [TBL] [Abstract][Full Text] [Related]
25. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine. Philippi C; Loretz B; Schaefer UF; Lehr CM J Control Release; 2010 Sep; 146(2):228-40. PubMed ID: 20381558 [TBL] [Abstract][Full Text] [Related]
26. Changing Direction: From Therapeutic Telomerase Inhibition to Activation? Bär C; Thum T Circ Res; 2017 Apr; 120(9):1393-1395. PubMed ID: 28450362 [No Abstract] [Full Text] [Related]
27. Telomeres, telomerase and cancer: is the magic bullet real? Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664 [TBL] [Abstract][Full Text] [Related]
29. A 6-mer photocontrolled oligonucleotide as an effective telomerase inhibitor. Xu Y; Ito K; Suzuki Y; Komiyama M J Am Chem Soc; 2010 Jan; 132(2):631-7. PubMed ID: 20014834 [TBL] [Abstract][Full Text] [Related]
30. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer. Sekhri K J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374 [TBL] [Abstract][Full Text] [Related]
32. Telomerase inhibitors: a new option for chemotherapy. Chen Z; Corey DR Adv Cancer Res; 2003; 87():31-58. PubMed ID: 12641273 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
35. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner. Tamakawa RA; Fleisig HB; Wong JM Cancer Res; 2010 Nov; 70(21):8684-94. PubMed ID: 20837664 [TBL] [Abstract][Full Text] [Related]
36. Telomerase and cancer therapeutics. Harley CB Nat Rev Cancer; 2008 Mar; 8(3):167-79. PubMed ID: 18256617 [TBL] [Abstract][Full Text] [Related]
37. Telomerase as a target for cancer therapy. Parkinson KE Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912 [TBL] [Abstract][Full Text] [Related]
38. Telomerase: anti-cancer target or just a fascinating enzyme? Hamilton SE; Corey DR Chem Biol; 1996 Nov; 3(11):863-7. PubMed ID: 8939712 [TBL] [Abstract][Full Text] [Related]
39. Design of telomerase inhibitors for the treatment of cancer. Cairns D; Anderson RJ; Perry PJ; Jenkins TC Curr Pharm Des; 2002; 8(27):2491-504. PubMed ID: 12369943 [TBL] [Abstract][Full Text] [Related]
40. Telomerase and telomeres: from basic biology to cancer treatment. Helder MN; Wisman GB; van der Zee GJ Cancer Invest; 2002; 20(1):82-101. PubMed ID: 11855380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]